MARKET

FLGT

FLGT

Fulgent Genetics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

60.70
-6.11
-9.15%
After Hours: 60.70 0 0.00% 19:59 01/21 EST
OPEN
64.76
PREV CLOSE
66.81
HIGH
65.56
LOW
60.59
VOLUME
818.98K
TURNOVER
--
52 WEEK HIGH
189.89
52 WEEK LOW
60.59
MARKET CAP
1.81B
P/E (TTM)
3.154
1D
5D
1M
3M
1Y
5Y
Inspirion Wealth Advisors, Llc Buys Janus Henderson Mortgage-Backed Securities ETF, Zscaler ...
Investment company Inspirion Wealth Advisors, Llc (Current Portfolio) buys Janus Henderson Mortgage-Backed Securities ETF, Zscaler Inc, Janus Henderson AAA CLO ETF, Hartford Total Return Bond ETF, WisdomTree U.S.
GuruFocus.com · 1d ago
Crossmark Global Holdings, Inc. Buys Cigna Corp, Honda Motor Co, Crown Castle International ...
Investment company Crossmark Global Holdings, Inc. (Current Portfolio) buys Cigna Corp, Honda Motor Co, Crown Castle International Corp, Telefonaktiebolaget L M Ericsson, Procter & Gamble Co, sells Eli Lilly and Co, Bank of America Corp, RELX PLC, Kirkland...
GuruFocus.com · 01/10 22:38
Biden says vaccinated people shouldn't be 'alarmed' by COVID-19
President Biden today said that those who have been vaccinated "should not be alarmed by COVID-19," but those who haven't been should be. Biden also said that it is highly
Seekingalpha · 01/04 20:59
4 Profitable Stocks to Boost Returns Using Net Income Ratio
FLGT, LGO, CTRN, and TGH have been selected as the top picks with a high net income ratio.
Zacks · 01/04 13:50
U.S. daily COVID-19 cases top 1 million as Omicron rages
According to data from Johns Hopkins University, more than 1 million people in the U.S. were diagnosed with COVID-19 on Monday as a tsunami of Omicron swamps the nation, Bloomberg
Seekingalpha · 01/04 08:00
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Benzinga · 01/03 17:36
Buy These 3 Stocks With Momentum Anomaly for Higher Returns
Zacks.com · 01/02 00:27
New Strong Buy Stocks for December 28th
Zacks.com · 01/02 00:25
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of FLGT. Analyze the recent business situations of Fulgent Genetics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

100.00%Strong Buy
0.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average FLGT stock price target is 141.00 with a high estimate of 141.00 and a low estimate of 141.00.
High141.00
Average141.00
Low141.00
Current 60.70
EPS
Actual
Estimate
1.633.264.896.52
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 288
Institutional Holdings: 11.91M
% Owned: 39.93%
Shares Outstanding: 29.83M
TypeInstitutionsShares
Increased
90
1.28M
New
41
423.62K
Decreased
75
783.30K
Sold Out
25
277.70K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-1.47%
Healthcare Providers & Services
-1.24%
Key Executives
Chairman/President/Chief Executive Officer/Director
Ming Hsieh
Chief Financial Officer
Paul Kim
Chief Operating Officer
Jian Xie
Chief Scientific Officer
Han Lin Gao
Independent Director
John Bolger
Independent Director
Linda Marsh
Independent Director
Yun Yen
No Data
About FLGT
Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. The Company's technology platform performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels that can be tailored to meet specific customer needs. The Company's product Picture Genetics, a new line of at-home screening tests that combines the company’s advanced Next generation sequencing (NGS) solutions with actionable results and genetic counseling options for individuals.

Webull offers kinds of Fulgent Genetics Inc stock information, including NASDAQ:FLGT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLGT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FLGT stock methods without spending real money on the virtual paper trading platform.